Catheter Ablation of Atrial Fibrillation: State of the Art and Future Perspectives

Purpose of Review Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with high rates of morbidity and mortality. Maintenance of stable sinus rhythm (SR) is the intended treatment target in symptomatic patients, and catheter ablation aimed at isolating the pulmonary veins p...

Full description

Saved in:
Bibliographic Details
Published inCardiology and Therapy Vol. 9; no. 1; pp. 45 - 58
Main Authors Rottner, Laura, Bellmann, Barbara, Lin, Tina, Reissmann, Bruno, Tönnis, Tobias, Schleberger, Ruben, Nies, Moritz, Jungen, Christiane, Dinshaw, Leon, Klatt, Niklas, Dickow, Jannis, Münkler, Paula, Meyer, Christian, Metzner, Andreas, Rillig, Andreas
Format Journal Article
LanguageEnglish
Published Cheshire Springer Healthcare 01.06.2020
Springer
Adis, Springer Healthcare
Subjects
Ablation techniques
AF sources
Anti-arrhythmia drugs
Atrial fibrillation
Cardiology
Catheter ablation
Cryoballoon
Dielectric mapping
Dosage and administration
Drug therapy
Internal Medicine
Medicine
Medicine & Public Health
Patient outcomes
Review
Germany
Rotor ablation
AF sources
Dielectric mapping
Atrial fibrillation
Catheter ablation
KODEX
Ablation techniques
EPD
Radiofrequency
Cryoballoon
Online AccessGet full text
ISSN2193-8261
2193-6544
DOI10.1007/s40119-019-00158-2

Cover

Abstract Purpose of Review Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with high rates of morbidity and mortality. Maintenance of stable sinus rhythm (SR) is the intended treatment target in symptomatic patients, and catheter ablation aimed at isolating the pulmonary veins provides the most effective treatment option, supported by encouraging clinical outcome data. A variety of energy sources and devices have been developed and evaluated. In this review, we summarize the current state of the art of catheter ablation of AF and describe future perspectives. Recent Findings Catheter ablation is a well-established treatment option for patients with symptomatic AF and is more successful at maintaining SR than antiarrhythmic drugs. Antral pulmonary vein isolation (PVI) as a stand-alone ablation strategy results in beneficial clinical outcomes and is therefore recommended as first-line strategy for both paroxysmal and persistent AF. While radiofrequency-based PVI in conjunction with a three-dimensional mapping system was for many years considered to be the “gold standard”, the cryoballoon has emerged as the most commonly used alternative AF ablation tool, especially in patients with paroxysmal AF. Patients with persistent or long-standing persistent AF and with arrhythmia recurrence after previous PVI may benefit from additional ablation strategies, such as substrate modification of various forms or left atrial appendage isolation. New technologies and techniques, such as identification of the AF sources and magnetic resonance imaging-guided substrate modification, are on the way to further improve the success rates of catheter ablation for selected patients and might help to further reduce arrhythmia recurrence. Conclusions Pulmonary vein isolation is the treatment of choice for symptomatic patients with paroxysmal and persistent drug-refractory AF. The reconnection of previously isolated pulmonary veins remains the major cause of AF recurrence. Novel ablation tools, such as balloon technologies or alternative energy sources, might help to overcome this limitation. Patients with non-paroxysmal AF and with AF recurrence might benefit from alternative ablation strategies. However, further studies are warranted to further improve our knowledge of the underlying mechanisms of AF and to obtain long-term clinical outcomes on new ablation techniques.
AbstractList Purpose of Review Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with high rates of morbidity and mortality. Maintenance of stable sinus rhythm (SR) is the intended treatment target in symptomatic patients, and catheter ablation aimed at isolating the pulmonary veins provides the most effective treatment option, supported by encouraging clinical outcome data. A variety of energy sources and devices have been developed and evaluated. In this review, we summarize the current state of the art of catheter ablation of AF and describe future perspectives. Recent Findings Catheter ablation is a well-established treatment option for patients with symptomatic AF and is more successful at maintaining SR than antiarrhythmic drugs. Antral pulmonary vein isolation (PVI) as a stand-alone ablation strategy results in beneficial clinical outcomes and is therefore recommended as first-line strategy for both paroxysmal and persistent AF. While radiofrequency-based PVI in conjunction with a three-dimensional mapping system was for many years considered to be the "gold standard", the cryoballoon has emerged as the most commonly used alternative AF ablation tool, especially in patients with paroxysmal AF. Patients with persistent or long-standing persistent AF and with arrhythmia recurrence after previous PVI may benefit from additional ablation strategies, such as substrate modification of various forms or left atrial appendage isolation. New technologies and techniques, such as identification of the AF sources and magnetic resonance imaging-guided substrate modification, are on the way to further improve the success rates of catheter ablation for selected patients and might help to further reduce arrhythmia recurrence. Conclusions Pulmonary vein isolation is the treatment of choice for symptomatic patients with paroxysmal and persistent drug-refractory AF. The reconnection of previously isolated pulmonary veins remains the major cause of AF recurrence. Novel ablation tools, such as balloon technologies or alternative energy sources, might help to overcome this limitation. Patients with non-paroxysmal AF and with AF recurrence might benefit from alternative ablation strategies. However, further studies are warranted to further improve our knowledge of the underlying mechanisms of AF and to obtain long-term clinical outcomes on new ablation techniques.
Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with high rates of morbidity and mortality. Maintenance of stable sinus rhythm (SR) is the intended treatment target in symptomatic patients, and catheter ablation aimed at isolating the pulmonary veins provides the most effective treatment option, supported by encouraging clinical outcome data. A variety of energy sources and devices have been developed and evaluated. In this review, we summarize the current state of the art of catheter ablation of AF and describe future perspectives. Catheter ablation is a well-established treatment option for patients with symptomatic AF and is more successful at maintaining SR than antiarrhythmic drugs. Antral pulmonary vein isolation (PVI) as a stand-alone ablation strategy results in beneficial clinical outcomes and is therefore recommended as first-line strategy for both paroxysmal and persistent AF. While radiofrequency-based PVI in conjunction with a three-dimensional mapping system was for many years considered to be the "gold standard", the cryoballoon has emerged as the most commonly used alternative AF ablation tool, especially in patients with paroxysmal AF. Patients with persistent or long-standing persistent AF and with arrhythmia recurrence after previous PVI may benefit from additional ablation strategies, such as substrate modification of various forms or left atrial appendage isolation. New technologies and techniques, such as identification of the AF sources and magnetic resonance imaging-guided substrate modification, are on the way to further improve the success rates of catheter ablation for selected patients and might help to further reduce arrhythmia recurrence. Pulmonary vein isolation is the treatment of choice for symptomatic patients with paroxysmal and persistent drug-refractory AF. The reconnection of previously isolated pulmonary veins remains the major cause of AF recurrence. Novel ablation tools, such as balloon technologies or alternative energy sources, might help to overcome this limitation. Patients with non-paroxysmal AF and with AF recurrence might benefit from alternative ablation strategies. However, further studies are warranted to further improve our knowledge of the underlying mechanisms of AF and to obtain long-term clinical outcomes on new ablation techniques.
Abstract Purpose of Review Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with high rates of morbidity and mortality. Maintenance of stable sinus rhythm (SR) is the intended treatment target in symptomatic patients, and catheter ablation aimed at isolating the pulmonary veins provides the most effective treatment option, supported by encouraging clinical outcome data. A variety of energy sources and devices have been developed and evaluated. In this review, we summarize the current state of the art of catheter ablation of AF and describe future perspectives. Recent Findings Catheter ablation is a well-established treatment option for patients with symptomatic AF and is more successful at maintaining SR than antiarrhythmic drugs. Antral pulmonary vein isolation (PVI) as a stand-alone ablation strategy results in beneficial clinical outcomes and is therefore recommended as first-line strategy for both paroxysmal and persistent AF. While radiofrequency-based PVI in conjunction with a three-dimensional mapping system was for many years considered to be the “gold standard”, the cryoballoon has emerged as the most commonly used alternative AF ablation tool, especially in patients with paroxysmal AF. Patients with persistent or long-standing persistent AF and with arrhythmia recurrence after previous PVI may benefit from additional ablation strategies, such as substrate modification of various forms or left atrial appendage isolation. New technologies and techniques, such as identification of the AF sources and magnetic resonance imaging-guided substrate modification, are on the way to further improve the success rates of catheter ablation for selected patients and might help to further reduce arrhythmia recurrence. Conclusions Pulmonary vein isolation is the treatment of choice for symptomatic patients with paroxysmal and persistent drug-refractory AF. The reconnection of previously isolated pulmonary veins remains the major cause of AF recurrence. Novel ablation tools, such as balloon technologies or alternative energy sources, might help to overcome this limitation. Patients with non-paroxysmal AF and with AF recurrence might benefit from alternative ablation strategies. However, further studies are warranted to further improve our knowledge of the underlying mechanisms of AF and to obtain long-term clinical outcomes on new ablation techniques.
Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with high rates of morbidity and mortality. Maintenance of stable sinus rhythm (SR) is the intended treatment target in symptomatic patients, and catheter ablation aimed at isolating the pulmonary veins provides the most effective treatment option, supported by encouraging clinical outcome data. A variety of energy sources and devices have been developed and evaluated. In this review, we summarize the current state of the art of catheter ablation of AF and describe future perspectives.PURPOSE OF REVIEWAtrial fibrillation (AF), the most common sustained arrhythmia, is associated with high rates of morbidity and mortality. Maintenance of stable sinus rhythm (SR) is the intended treatment target in symptomatic patients, and catheter ablation aimed at isolating the pulmonary veins provides the most effective treatment option, supported by encouraging clinical outcome data. A variety of energy sources and devices have been developed and evaluated. In this review, we summarize the current state of the art of catheter ablation of AF and describe future perspectives.Catheter ablation is a well-established treatment option for patients with symptomatic AF and is more successful at maintaining SR than antiarrhythmic drugs. Antral pulmonary vein isolation (PVI) as a stand-alone ablation strategy results in beneficial clinical outcomes and is therefore recommended as first-line strategy for both paroxysmal and persistent AF. While radiofrequency-based PVI in conjunction with a three-dimensional mapping system was for many years considered to be the "gold standard", the cryoballoon has emerged as the most commonly used alternative AF ablation tool, especially in patients with paroxysmal AF. Patients with persistent or long-standing persistent AF and with arrhythmia recurrence after previous PVI may benefit from additional ablation strategies, such as substrate modification of various forms or left atrial appendage isolation. New technologies and techniques, such as identification of the AF sources and magnetic resonance imaging-guided substrate modification, are on the way to further improve the success rates of catheter ablation for selected patients and might help to further reduce arrhythmia recurrence.RECENT FINDINGSCatheter ablation is a well-established treatment option for patients with symptomatic AF and is more successful at maintaining SR than antiarrhythmic drugs. Antral pulmonary vein isolation (PVI) as a stand-alone ablation strategy results in beneficial clinical outcomes and is therefore recommended as first-line strategy for both paroxysmal and persistent AF. While radiofrequency-based PVI in conjunction with a three-dimensional mapping system was for many years considered to be the "gold standard", the cryoballoon has emerged as the most commonly used alternative AF ablation tool, especially in patients with paroxysmal AF. Patients with persistent or long-standing persistent AF and with arrhythmia recurrence after previous PVI may benefit from additional ablation strategies, such as substrate modification of various forms or left atrial appendage isolation. New technologies and techniques, such as identification of the AF sources and magnetic resonance imaging-guided substrate modification, are on the way to further improve the success rates of catheter ablation for selected patients and might help to further reduce arrhythmia recurrence.Pulmonary vein isolation is the treatment of choice for symptomatic patients with paroxysmal and persistent drug-refractory AF. The reconnection of previously isolated pulmonary veins remains the major cause of AF recurrence. Novel ablation tools, such as balloon technologies or alternative energy sources, might help to overcome this limitation. Patients with non-paroxysmal AF and with AF recurrence might benefit from alternative ablation strategies. However, further studies are warranted to further improve our knowledge of the underlying mechanisms of AF and to obtain long-term clinical outcomes on new ablation techniques.CONCLUSIONSPulmonary vein isolation is the treatment of choice for symptomatic patients with paroxysmal and persistent drug-refractory AF. The reconnection of previously isolated pulmonary veins remains the major cause of AF recurrence. Novel ablation tools, such as balloon technologies or alternative energy sources, might help to overcome this limitation. Patients with non-paroxysmal AF and with AF recurrence might benefit from alternative ablation strategies. However, further studies are warranted to further improve our knowledge of the underlying mechanisms of AF and to obtain long-term clinical outcomes on new ablation techniques.
Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with high rates of morbidity and mortality. Maintenance of stable sinus rhythm (SR) is the intended treatment target in symptomatic patients, and catheter ablation aimed at isolating the pulmonary veins provides the most effective treatment option, supported by encouraging clinical outcome data. A variety of energy sources and devices have been developed and evaluated. In this review, we summarize the current state of the art of catheter ablation of AF and describe future perspectives. Pulmonary vein isolation is the treatment of choice for symptomatic patients with paroxysmal and persistent drug-refractory AF. The reconnection of previously isolated pulmonary veins remains the major cause of AF recurrence. Novel ablation tools, such as balloon technologies or alternative energy sources, might help to overcome this limitation. Patients with non-paroxysmal AF and with AF recurrence might benefit from alternative ablation strategies. However, further studies are warranted to further improve our knowledge of the underlying mechanisms of AF and to obtain long-term clinical outcomes on new ablation techniques.
Purpose of Review Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with high rates of morbidity and mortality. Maintenance of stable sinus rhythm (SR) is the intended treatment target in symptomatic patients, and catheter ablation aimed at isolating the pulmonary veins provides the most effective treatment option, supported by encouraging clinical outcome data. A variety of energy sources and devices have been developed and evaluated. In this review, we summarize the current state of the art of catheter ablation of AF and describe future perspectives. Recent Findings Catheter ablation is a well-established treatment option for patients with symptomatic AF and is more successful at maintaining SR than antiarrhythmic drugs. Antral pulmonary vein isolation (PVI) as a stand-alone ablation strategy results in beneficial clinical outcomes and is therefore recommended as first-line strategy for both paroxysmal and persistent AF. While radiofrequency-based PVI in conjunction with a three-dimensional mapping system was for many years considered to be the “gold standard”, the cryoballoon has emerged as the most commonly used alternative AF ablation tool, especially in patients with paroxysmal AF. Patients with persistent or long-standing persistent AF and with arrhythmia recurrence after previous PVI may benefit from additional ablation strategies, such as substrate modification of various forms or left atrial appendage isolation. New technologies and techniques, such as identification of the AF sources and magnetic resonance imaging-guided substrate modification, are on the way to further improve the success rates of catheter ablation for selected patients and might help to further reduce arrhythmia recurrence. Conclusions Pulmonary vein isolation is the treatment of choice for symptomatic patients with paroxysmal and persistent drug-refractory AF. The reconnection of previously isolated pulmonary veins remains the major cause of AF recurrence. Novel ablation tools, such as balloon technologies or alternative energy sources, might help to overcome this limitation. Patients with non-paroxysmal AF and with AF recurrence might benefit from alternative ablation strategies. However, further studies are warranted to further improve our knowledge of the underlying mechanisms of AF and to obtain long-term clinical outcomes on new ablation techniques.
Audience Academic
Author Reissmann, Bruno
Rottner, Laura
Metzner, Andreas
Münkler, Paula
Meyer, Christian
Rillig, Andreas
Nies, Moritz
Dinshaw, Leon
Dickow, Jannis
Bellmann, Barbara
Lin, Tina
Tönnis, Tobias
Klatt, Niklas
Jungen, Christiane
Schleberger, Ruben
Author_xml – sequence: 1
  givenname: Laura
  orcidid: 0000-0002-1389-8564
  surname: Rottner
  fullname: Rottner, Laura
  email: laurarottner@aol.de
  organization: Universitäres Herzzentrum Hamburg-Eppendorf
– sequence: 2
  givenname: Barbara
  surname: Bellmann
  fullname: Bellmann, Barbara
  organization: MEDIAN Klinik AGZ Düsseldorf
– sequence: 3
  givenname: Tina
  surname: Lin
  fullname: Lin, Tina
  organization: GenesisCare
– sequence: 4
  givenname: Bruno
  surname: Reissmann
  fullname: Reissmann, Bruno
  organization: Universitäres Herzzentrum Hamburg-Eppendorf
– sequence: 5
  givenname: Tobias
  surname: Tönnis
  fullname: Tönnis, Tobias
  organization: Universitäres Herzzentrum Hamburg-Eppendorf
– sequence: 6
  givenname: Ruben
  surname: Schleberger
  fullname: Schleberger, Ruben
  organization: Universitäres Herzzentrum Hamburg-Eppendorf
– sequence: 7
  givenname: Moritz
  surname: Nies
  fullname: Nies, Moritz
  organization: Universitäres Herzzentrum Hamburg-Eppendorf
– sequence: 8
  givenname: Christiane
  surname: Jungen
  fullname: Jungen, Christiane
  organization: Universitäres Herzzentrum Hamburg-Eppendorf
– sequence: 9
  givenname: Leon
  surname: Dinshaw
  fullname: Dinshaw, Leon
  organization: Universitäres Herzzentrum Hamburg-Eppendorf
– sequence: 10
  givenname: Niklas
  surname: Klatt
  fullname: Klatt, Niklas
  organization: Universitäres Herzzentrum Hamburg-Eppendorf
– sequence: 11
  givenname: Jannis
  surname: Dickow
  fullname: Dickow, Jannis
  organization: Universitäres Herzzentrum Hamburg-Eppendorf
– sequence: 12
  givenname: Paula
  surname: Münkler
  fullname: Münkler, Paula
  organization: Universitäres Herzzentrum Hamburg-Eppendorf
– sequence: 13
  givenname: Christian
  surname: Meyer
  fullname: Meyer, Christian
  organization: Universitäres Herzzentrum Hamburg-Eppendorf
– sequence: 14
  givenname: Andreas
  surname: Metzner
  fullname: Metzner, Andreas
  organization: Universitäres Herzzentrum Hamburg-Eppendorf
– sequence: 15
  givenname: Andreas
  surname: Rillig
  fullname: Rillig, Andreas
  organization: Universitäres Herzzentrum Hamburg-Eppendorf
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31898209$$D View this record in MEDLINE/PubMed
BookMark eNp9kl1rFDEUhgep2Fr7B7yQAW-8mZrvDy-EZXG1UFD8uA6ZzJltyuxkTTIF_72ZzlZckTKECSfv-3CS8z6vTsYwQlW9xOgSIyTfJoYw1g2aF8JcNeRJdUawpo3gjJ0c9ooIfFpdpORbxJikhAv0rDqlWGlFkD6rvq5tvoEMsV61g80-jHXo61WO3g71xrfRD0v5Xf0t2wzzaTHUq5hrO3b1ZspThPoLxLQHl_0dpBfV094OCS4O__Pqx-bD9_Wn5vrzx6v16rpxXOrcWAcWuJQdklSD6hjiTGgmJbe4A9BAhbJIOkV6jBVmGlGBSOtIyy0XltDz6mrhdsHemn30Oxt_mWC9uS-EuDU2Zu8GMIw51-nybphQRolWGjPU0x472tqe8cJ6v7D2U7uDzsGYox2OoMcno78x23BnJKFSIFoAbw6AGH5OkLLZ-eSgPN4IYUqGUEoFRkLJIn29SLe2tObHPhSim-VmJXjpsAx2vt3lf1Tl62DnXclC70v9yPDq7yv86f1h1kWgFoGLIaUIvXE-38-2kP1gMDJzssySLIPmNSfLzGzyj_WB_qiJLqZUxOMWorkNUxxLJB5z_QYx0tzi
CitedBy_id crossref_primary_10_3390_healthcare12151508
crossref_primary_10_1016_j_hrcr_2021_05_018
crossref_primary_10_2217_fca_2020_0066
crossref_primary_10_7759_cureus_59407
crossref_primary_10_61189_061485jysfwu
crossref_primary_10_1186_s12872_022_02657_y
crossref_primary_10_1016_j_tcm_2022_04_002
crossref_primary_10_1080_14779072_2021_1902307
crossref_primary_10_1002_joa3_12742
crossref_primary_10_26599_1671_5411_2023_11_006
crossref_primary_10_1111_jce_15072
crossref_primary_10_1007_s10840_023_01690_x
crossref_primary_10_1007_s10840_022_01308_8
crossref_primary_10_1111_pace_14324
crossref_primary_10_1007_s12551_020_00735_z
crossref_primary_10_1038_s42005_022_00978_0
crossref_primary_10_7759_cureus_65835
crossref_primary_10_1007_s12195_021_00703_x
crossref_primary_10_17925_EJAE_2021_7_1_26
crossref_primary_10_1155_2021_5511267
crossref_primary_10_1371_journal_pone_0259999
crossref_primary_10_1002_advs_202307427
crossref_primary_10_1080_00015385_2021_1939512
crossref_primary_10_1016_j_cpcardiol_2022_101161
crossref_primary_10_36660_abc_20240246i
crossref_primary_10_1002_joa3_12856
crossref_primary_10_3389_fcvm_2024_1327639
crossref_primary_10_1111_eci_13499
crossref_primary_10_38025_2078_1962_2023_22_2_120_128
crossref_primary_10_1161_CIRCEP_120_009219
crossref_primary_10_3390_jcm13164958
crossref_primary_10_1097_HCO_0000000000001182
crossref_primary_10_18087_cardio_2023_1_n2124
crossref_primary_10_2147_CIA_S376091
crossref_primary_10_1088_1361_6579_acbc08
crossref_primary_10_1161_CIRCEP_121_010174
crossref_primary_10_2174_1573403X17666210729101752
crossref_primary_10_26565_2313_6693_2021_43_02
crossref_primary_10_7759_cureus_72437
crossref_primary_10_1007_s00399_022_00843_1
crossref_primary_10_1007_s10840_022_01212_1
crossref_primary_10_1186_s12872_020_01670_3
crossref_primary_10_23736_S2724_5683_20_05217_2
crossref_primary_10_1007_s40430_024_04702_7
crossref_primary_10_1093_eurheartj_ehae618
crossref_primary_10_1016_j_jvc_2023_07_001
crossref_primary_10_1016_j_hrthm_2022_06_016
crossref_primary_10_36660_abc_20240246
crossref_primary_10_3390_jcm13041029
crossref_primary_10_1093_ehjcr_ytae303
crossref_primary_10_1016_j_bspc_2020_102354
crossref_primary_10_3390_s24051699
crossref_primary_10_3390_ijms242015248
crossref_primary_10_1007_s00392_021_01874_3
crossref_primary_10_1007_s10554_021_02493_9
crossref_primary_10_1016_j_ijcard_2022_06_019
crossref_primary_10_3389_fpsyt_2025_1467876
crossref_primary_10_1186_s43044_025_00605_7
crossref_primary_10_3389_fphys_2021_733449
crossref_primary_10_3390_ijms22115937
crossref_primary_10_1007_s00399_022_00902_7
crossref_primary_10_1002_prp2_880
crossref_primary_10_1007_s00392_020_01763_1
crossref_primary_10_1038_s41598_023_49475_6
Cites_doi 10.1056/NEJMoa1602014
10.1093/eurheartj/ehn453
10.1136/heartjnl-2011-301107
10.1111/jce.13310
10.1016/j.hrthm.2015.03.011
10.1093/europace/euw295
10.1111/j.1540-8167.2009.01454.x
10.1161/CIRCEP.119.007233
10.1001/jama.2014.3
10.1111/j.1540-8167.2007.00760.x
10.1161/CIRCEP.117.005114
10.1111/jce.12075
10.1001/jama.2019.0693
10.1161/CIRCEP.113.000374
10.1111/jce.13472
10.1007/s10840-014-9947-2
10.1111/jce.13401
10.1161/CIRCULATIONAHA.110.946806
10.1001/archinte.168.6.581
10.1016/j.hrthm.2016.11.008
10.1056/NEJMoa1408288
10.1007/s10840-018-0322-6
10.2217/fca.15.68
10.1161/JAHA.114.000877
10.1056/NEJM199809033391003
10.1093/europace/euy239
10.1001/jamacardio.2018.1176
10.1016/j.ahj.2018.05.021
10.1111/jce.12820
10.1161/CIRCEP.116.004672
10.1161/CIRCEP.117.005861
10.1016/j.hrthm.2017.05.012
10.1161/CIRCEP.113.000556
10.1016/j.hrthm.2015.12.028
10.1093/europace/euv092
10.1016/j.ijcard.2019.02.006
10.1016/j.jacep.2018.06.005
10.1016/j.jacc.2015.09.088
10.1161/CIRCULATIONAHA.105.561183
10.1016/j.hrthm.2015.05.019
10.1161/CIRCEP.115.002962
10.1016/j.ijcard.2013.08.083
10.1093/europace/eux219
10.1093/europace/euv057
10.1093/europace/euw168
10.1161/CIRCEP.113.000431
10.1016/j.jacep.2017.11.018
10.1016/j.hrthm.2012.07.016
10.1161/CIRCULATIONAHA.118.037451
10.1016/j.ccep.2014.11.007
10.1111/j.1540-8167.2012.02427.x
10.1016/j.jacc.2012.05.022
10.1016/j.jacc.2016.07.770
10.1016/j.jacc.2007.10.044
10.1007/s00392-017-1199-6
10.1007/s00392-018-1274-7
10.1161/CIRCEP.117.005250
10.1016/j.jacep.2017.01.024
10.1111/jce.13160
10.1093/eurheartj/ehq041
10.1007/s10840-012-9733-y
10.1093/europace/eup192
10.1161/CIRCEP.118.006576
10.1161/JAHA.118.010777
10.1093/europace/eux005
10.1001/archinte.1995.00430050045005
10.1007/s00392-015-0892-6
10.1161/CIRCEP.109.859116
10.1001/jama.2019.0335
10.1007/s10840-017-0261-7
10.1007/s00392-016-1008-7
10.1016/j.jelectrocard.2010.09.007
10.1161/CIRCEP.115.003461
10.1161/CIRCEP.117.005767
10.1016/j.jacep.2019.04.009
10.1016/j.jacep.2018.07.007
10.1007/s00392-019-01428-8
10.1111/jce.13989
10.1016/j.jacep.2019.06.020
ContentType Journal Article
Copyright The Author(s) 2020
COPYRIGHT 2020 Springer
Copyright_xml – notice: The Author(s) 2020
– notice: COPYRIGHT 2020 Springer
DBID C6C
AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1007/s40119-019-00158-2
DatabaseName WRHA-SpringerOpen Free
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2193-6544
EndPage 58
ExternalDocumentID oai_doaj_org_article_44ccd9100123432989140f3f1c3baf45
PMC7237603
A651230112
31898209
10_1007_s40119_019_00158_2
Genre Journal Article
Review
GeographicLocations Germany
GeographicLocations_xml – name: Germany
GroupedDBID -A0
0R~
3V.
4.4
5VS
7X7
8AO
8FI
8FJ
AAKKN
ABDBF
ABEEZ
ABUWG
ACACY
ACGFS
ACUHS
ACULB
ADBBV
ADINQ
ADRAZ
AFGXO
AFKRA
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
C24
C6C
CCPQU
DIK
EBS
EJD
FYUFA
GROUPED_DOAJ
H13
HMCUK
HYE
HZ~
IAO
IHR
ITC
KQ8
M48
M~E
O9-
OK1
PGMZT
PIMPY
PQQKQ
PROAC
RPM
RSV
SISQX
SMD
SOJ
UKHRP
~JE
AAYXX
CITATION
PHGZM
PHGZT
NPM
7X8
5PM
ID FETCH-LOGICAL-c579t-aceae577d0739e8d4054694775a1dee9e368a07c82f11814903602bc2b5a56a23
IEDL.DBID C24
ISSN 2193-8261
IngestDate Wed Aug 27 01:24:07 EDT 2025
Thu Aug 21 13:55:02 EDT 2025
Thu Jul 10 22:43:18 EDT 2025
Wed Mar 19 02:14:47 EDT 2025
Sat Mar 08 18:56:29 EST 2025
Thu Jan 02 22:27:56 EST 2025
Tue Jul 01 02:20:57 EDT 2025
Thu Apr 24 23:13:16 EDT 2025
Fri Feb 21 02:40:25 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Rotor ablation
AF sources
Dielectric mapping
Atrial fibrillation
Catheter ablation
KODEX
Ablation techniques
EPD
Radiofrequency
Cryoballoon
Language English
License This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c579t-aceae577d0739e8d4054694775a1dee9e368a07c82f11814903602bc2b5a56a23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0002-1389-8564
OpenAccessLink https://link.springer.com/10.1007/s40119-019-00158-2
PMID 31898209
PQID 2333610687
PQPubID 23479
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_44ccd9100123432989140f3f1c3baf45
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7237603
proquest_miscellaneous_2333610687
gale_infotracmisc_A651230112
gale_infotracacademiconefile_A651230112
pubmed_primary_31898209
crossref_citationtrail_10_1007_s40119_019_00158_2
crossref_primary_10_1007_s40119_019_00158_2
springer_journals_10_1007_s40119_019_00158_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-06-01
PublicationDateYYYYMMDD 2020-06-01
PublicationDate_xml – month: 06
  year: 2020
  text: 2020-06-01
  day: 01
PublicationDecade 2020
PublicationPlace Cheshire
PublicationPlace_xml – name: Cheshire
– name: England
PublicationTitle Cardiology and Therapy
PublicationTitleAbbrev Cardiol Ther
PublicationTitleAlternate Cardiol Ther
PublicationYear 2020
Publisher Springer Healthcare
Springer
Adis, Springer Healthcare
Publisher_xml – name: Springer Healthcare
– name: Springer
– name: Adis, Springer Healthcare
References Brooks, Metzner, Wohlmuth (CR12) 2018; 29
Thomas, Katus, Voss (CR46) 2011; 44
Schmidt, Neuzil, Luik (CR53) 2017; 10
Sohns, Saguner, Lemes (CR32) 2016; 105
Fink, Schluter, Heeger (CR16) 2017; 10
Knecht, Sohal, Deisenhofer (CR68) 2017; 19
Kottkamp, Moser, Rieger, Schreiber, Ponisch, Trofin (CR57) 2017; 28
Yorgun, Canpolat, Kocyigit, Coteli, Evranos, Aytemir (CR72) 2017; 19
Verma, Jiang, Betts (CR17) 2015; 372
Calkins, Hindricks, Cappato (CR8) 2017; 14
Rottner, Fink, Heeger (CR45) 2017; 20
Nagashima, Okumura, Watanabe (CR55) 2018; 11
Reddy, Shah, Kautzner (CR39) 2012; 9
Narayan, Krummen, Shivkumar, Clopton, Rappel, Miller (CR61) 2012; 60
Leshem, Zilberman, Tschabrunn (CR79) 2018; 4
Powell, Packer (CR24) 2009; 11
Stabile, Solimene, Calo (CR41) 2015; 42
Maille, Das, Hussein (CR30) 2018; 29
Cheema, Dong, Dalal (CR38) 2007; 18
Ouyang, Ernst, Chun (CR23) 2005; 112
Tokutake, Tokuda, Ogawa, Matsuo, Yoshimura, Yamane (CR47) 2017; 3
Dukkipati, Kuck, Neuzil (CR52) 2013; 6
Steinberg, Shah, Bhatt, Sichrovsky, Arshad, Hansinger (CR64) 2017; 14
Haissaguerre, Jais, Shah (CR15) 1998; 339
Mun, Joung, Shim (CR21) 2012; 98
Anter, Tschabrunn, Contreras-Valdes, Li, Josephson (CR33) 2015; 12
Reissmann, Budelmann, Wissner (CR7) 2018; 107
Metzner, Wissner, Schmidt (CR51) 2013; 24
Bhaskaran, Chik, Pouliopoulos (CR78) 2017; 19
Kuck, Brugada, Furnkranz (CR6) 2016; 374
Mortsell, Arbelo, Dagres (CR49) 2019; 21
Willems, Verma, Betts, Murray, Neuzil, Ince (CR83) 2019; 12
Mohanty, Gianni, Trivedi (CR62) 2018; 205
Rillig, Lin, Schmidt (CR26) 2016; 105
CR48
Kistler, Rajappan, Harris (CR25) 2008; 29
Di Biase, Burkhardt, Mohanty (CR71) 2016; 68
Neuzil, Reddy, Kautzner (CR37) 2013; 6
Makimoto, Lin, Rillig (CR40) 2014; 7
CR43
Noheria, Kumar, Wylie, Josephson (CR9) 2008; 168
Kuck, Brugada, Schluter (CR14) 2018; 7
CR82
Weerasooriya, Jais, Wright (CR29) 2009; 20
Ouyang, Tilz, Chun (CR11) 2010; 122
Cappato, Calkins, Chen (CR22) 2010; 3
Heeger, Rillig, Geisler (CR73) 2019; 139
Heeger, Rillig, Lin (CR75) 2015; 12
Go, Reynolds, Yang (CR13) 2018; 3
Neven, van Es, van Driel (CR77) 2017; 10
Winkle, Moskovitz, Hardwin Mead (CR80) 2018; 52
Rottner, Metzner, Ouyang (CR35) 2017; 28
Marrouche, Wilber, Hindricks (CR69) 2014; 311
Packer, Mark, Robb (CR3) 2019; 321
Haissaguerre, Hocini, Shah (CR67) 2013; 24
Kautzner, Neuzil, Lambert (CR36) 2015; 17
Ptaszek, Chalhoub, Perna (CR31) 2013; 36
Wissner, Deiss, Kuck (CR50) 2015; 11
CR56
Tilz, Heeger, Wick (CR10) 2018; 11
Verma, Mantovan, Macle (CR19) 2010; 31
Wittkampf, van Es, Neven (CR76) 2018; 4
Wu, Jiang, Gu (CR60) 2013; 169
Blomstrom-Lundqvist, Gizurarson, Schwieler (CR5) 2019; 321
Maurer, Sohns, Deiss (CR28) 2017; 49
Reddy, Grimaldi, De Potter (CR81) 2019; 5
Hussein, Das, Riva (CR44) 2018; 11
Ernst, Saenen, Rydman (CR34) 2015; 7
Vogler, Willems, Sultan (CR18) 2015; 66
Feinberg, Blackshear, Laupacis, Kronmal, Hart (CR1) 1995; 155
Kirchhof, Benussi, Kotecha (CR2) 2016; 18
Das, Loveday, Wynn (CR42) 2017; 19
Bellmann, Lin, Ruppersberg (CR65) 2018; 107
Nademanee, Schwab, Kosar (CR59) 2008; 51
Rillig, Tilz, Lin (CR74) 2016; 9
Bellmann, Zettwitz, Lin (CR66) 2019; 286
Arbelo, Guiu, Ramos (CR20) 2014; 3
Gianni, Mohanty, Di Biase (CR63) 2016; 13
Jadidi, Lehrmann, Keyl (CR70) 2016; 9
Marrouche, Kheirkhahan, Brachmann (CR4) 2018; 379
Yamaguchi, Sohara, Takeda (CR54) 2015; 26
Rillig, Schmidt, Di Biase (CR27) 2017; 3
Lemes, Wissner, Lin (CR58) 2016; 18
P Kirchhof (158_CR2) 2016; 18
C Blomstrom-Lundqvist (158_CR5) 2019; 321
JS Steinberg (158_CR64) 2017; 14
L Di Biase (158_CR71) 2016; 68
VY Reddy (158_CR81) 2019; 5
Y Yamaguchi (158_CR54) 2015; 26
A Rillig (158_CR74) 2016; 9
A Rillig (158_CR27) 2017; 3
M Haissaguerre (158_CR67) 2013; 24
A Hussein (158_CR44) 2018; 11
S Ernst (158_CR34) 2015; 7
DL Packer (158_CR3) 2019; 321
M Haissaguerre (158_CR15) 1998; 339
NF Marrouche (158_CR69) 2014; 311
B Schmidt (158_CR53) 2017; 10
E Leshem (158_CR79) 2018; 4
SH Wu (158_CR60) 2013; 169
A Bhaskaran (158_CR78) 2017; 19
T Maurer (158_CR28) 2017; 49
A Verma (158_CR17) 2015; 372
NF Marrouche (158_CR4) 2018; 379
P Neuzil (158_CR37) 2013; 6
F Ouyang (158_CR11) 2010; 122
K Nagashima (158_CR55) 2018; 11
A Verma (158_CR19) 2010; 31
L Rottner (158_CR35) 2017; 28
S Brooks (158_CR12) 2018; 29
A Cheema (158_CR38) 2007; 18
K Nademanee (158_CR59) 2008; 51
A Metzner (158_CR51) 2013; 24
LM Ptaszek (158_CR31) 2013; 36
K Tokutake (158_CR47) 2017; 3
SR Dukkipati (158_CR52) 2013; 6
S Willems (158_CR83) 2019; 12
G Stabile (158_CR41) 2015; 42
F Ouyang (158_CR23) 2005; 112
K Neven (158_CR77) 2017; 10
J Vogler (158_CR18) 2015; 66
KH Kuck (158_CR14) 2018; 7
C Sohns (158_CR32) 2016; 105
158_CR56
A Noheria (158_CR9) 2008; 168
BD Powell (158_CR24) 2009; 11
A Rillig (158_CR26) 2016; 105
H Kottkamp (158_CR57) 2017; 28
D Thomas (158_CR46) 2011; 44
AS Go (158_CR13) 2018; 3
E Anter (158_CR33) 2015; 12
C Lemes (158_CR58) 2016; 18
S Mohanty (158_CR62) 2018; 205
WM Feinberg (158_CR1) 1995; 155
M Das (158_CR42) 2017; 19
HS Mun (158_CR21) 2012; 98
S Knecht (158_CR68) 2017; 19
C Gianni (158_CR63) 2016; 13
L Rottner (158_CR45) 2017; 20
SM Narayan (158_CR61) 2012; 60
B Maille (158_CR30) 2018; 29
KH Kuck (158_CR6) 2016; 374
H Calkins (158_CR8) 2017; 14
J Kautzner (158_CR36) 2015; 17
158_CR48
158_CR43
E Wissner (158_CR50) 2015; 11
AS Jadidi (158_CR70) 2016; 9
158_CR82
CH Heeger (158_CR75) 2015; 12
H Yorgun (158_CR72) 2017; 19
D Mortsell (158_CR49) 2019; 21
B Reissmann (158_CR7) 2018; 107
R Cappato (158_CR22) 2010; 3
E Arbelo (158_CR20) 2014; 3
B Bellmann (158_CR66) 2019; 286
T Fink (158_CR16) 2017; 10
B Bellmann (158_CR65) 2018; 107
VY Reddy (158_CR39) 2012; 9
FHM Wittkampf (158_CR76) 2018; 4
RR Tilz (158_CR10) 2018; 11
H Makimoto (158_CR40) 2014; 7
RA Winkle (158_CR80) 2018; 52
R Weerasooriya (158_CR29) 2009; 20
PM Kistler (158_CR25) 2008; 29
CH Heeger (158_CR73) 2019; 139
References_xml – volume: 379
  start-page: 492
  issue: 5
  year: 2018
  ident: CR4
  article-title: Catheter ablation for atrial fibrillation with heart failure
  publication-title: N Engl J Med
– volume: 374
  start-page: 2235
  issue: 23
  year: 2016
  end-page: 2245
  ident: CR6
  article-title: Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1602014
– volume: 29
  start-page: 3029
  issue: 24
  year: 2008
  end-page: 3036
  ident: CR25
  article-title: The impact of image integration on catheter ablation of atrial fibrillation using electroanatomic mapping: a prospective randomized study
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehn453
– volume: 98
  start-page: 480
  issue: 6
  year: 2012
  end-page: 484
  ident: CR21
  article-title: Does additional linear ablation after circumferential pulmonary vein isolation improve clinical outcome in patients with paroxysmal atrial fibrillation? Prospective randomised study
  publication-title: Heart
  doi: 10.1136/heartjnl-2011-301107
– volume: 28
  start-page: 1247
  issue: 11
  year: 2017
  end-page: 1256
  ident: CR57
  article-title: Global multielectrode contact mapping plus ablation with a single catheter: preclinical and preliminary experience in humans with atrial fibrillation
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/jce.13310
– volume: 12
  start-page: 1524
  issue: 7
  year: 2015
  end-page: 1531
  ident: CR75
  article-title: Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2015.03.011
– volume: 18
  start-page: 1609
  issue: 11
  year: 2016
  end-page: 1678
  ident: CR2
  article-title: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
  publication-title: Europace
  doi: 10.1093/europace/euw295
– volume: 20
  start-page: 833
  issue: 7
  year: 2009
  end-page: 838
  ident: CR29
  article-title: Catheter ablation of atrial tachycardia following atrial fibrillation ablation
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/j.1540-8167.2009.01454.x
– volume: 12
  start-page: e007233
  year: 2019
  ident: CR83
  article-title: Targeting nonpulmonary vein sources in persistent atrial fibrillation identified by noncontact charge density mapping (UNCOVER-AF trial)
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.119.007233
– volume: 311
  start-page: 498
  issue: 5
  year: 2014
  end-page: 506
  ident: CR69
  article-title: Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study
  publication-title: JAMA
  doi: 10.1001/jama.2014.3
– volume: 18
  start-page: 387
  issue: 4
  year: 2007
  end-page: 391
  ident: CR38
  article-title: Incidence and time course of early recovery of pulmonary vein conduction after catheter ablation of atrial fibrillation
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/j.1540-8167.2007.00760.x
– volume: 10
  start-page: e005114
  issue: 7
  year: 2017
  ident: CR16
  article-title: Stand-alone pulmonary vein isolation versus pulmonary vein isolation with additional substrate modification as index ablation procedures in patients with persistent and long-standing persistent atrial fibrillation: the randomized Alster-Lost-AF Trial (Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation)
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.117.005114
– volume: 24
  start-page: 711
  issue: 6
  year: 2013
  end-page: 717
  ident: CR67
  article-title: Noninvasive panoramic mapping of human atrial fibrillation mechanisms: a feasibility report
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/jce.12075
– volume: 321
  start-page: 1261
  year: 2019
  end-page: 1274
  ident: CR3
  article-title: Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: The CABANA randomized clinical trial
  publication-title: JAMA
  doi: 10.1001/jama.2019.0693
– volume: 6
  start-page: 327
  issue: 2
  year: 2013
  end-page: 333
  ident: CR37
  article-title: Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.113.000374
– volume: 29
  start-page: 881
  issue: 6
  year: 2018
  end-page: 888
  ident: CR30
  article-title: Accuracy of left atrial bipolar voltages obtained by ConfiDENSE multielectrode mapping in patients with persistent atrial fibrillation
  publication-title: J Cardiovasc Eelectrophysiol
  doi: 10.1111/jce.13472
– volume: 42
  start-page: 21
  issue: 1
  year: 2015
  end-page: 26
  ident: CR41
  article-title: Catheter-tissue contact force values do not impact mid-term clinical outcome following pulmonary vein isolation in patients with paroxysmal atrial fibrillation
  publication-title: J Interv Card Electrophysiol
  doi: 10.1007/s10840-014-9947-2
– volume: 29
  start-page: 257
  issue: 2
  year: 2018
  end-page: 263
  ident: CR12
  article-title: Insights into ablation of persistent atrial fibrillation: lessons from 6-year clinical outcomes
  publication-title: J Cardiovasc Elektrophysiol
  doi: 10.1111/jce.13401
– volume: 122
  start-page: 2368
  issue: 23
  year: 2010
  end-page: 2377
  ident: CR11
  article-title: Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.110.946806
– volume: 168
  start-page: 581
  issue: 6
  year: 2008
  end-page: 586
  ident: CR9
  article-title: Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review
  publication-title: Arch Int Med
  doi: 10.1001/archinte.168.6.581
– volume: 14
  start-page: 192
  issue: 2
  year: 2017
  end-page: 197
  ident: CR64
  article-title: Focal impulse and rotor modulation: acute procedural observations and extended clinical follow-up
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2016.11.008
– volume: 372
  start-page: 1812
  issue: 19
  year: 2015
  end-page: 1822
  ident: CR17
  article-title: Approaches to catheter ablation for persistent atrial fibrillation
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1408288
– volume: 52
  start-page: 1
  issue: 1
  year: 2018
  end-page: 8
  ident: CR80
  article-title: Atrial fibrillation ablation using very short duration 50 W ablations and contact force sensing catheters
  publication-title: J Interv Card Electrophysiol
  doi: 10.1007/s10840-018-0322-6
– volume: 11
  start-page: 663
  issue: 6
  year: 2015
  end-page: 671
  ident: CR50
  article-title: Balloon-based pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation (cryoballoon and laserballoon)
  publication-title: Fut Cardiol
  doi: 10.2217/fca.15.68
– volume: 3
  start-page: e000877
  issue: 5
  year: 2014
  ident: CR20
  article-title: Benefit of left atrial roof linear ablation in paroxysmal atrial fibrillation: a prospective, randomized study
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.114.000877
– volume: 339
  start-page: 659
  issue: 10
  year: 1998
  end-page: 666
  ident: CR15
  article-title: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199809033391003
– volume: 21
  start-page: 581
  issue: 4
  year: 2019
  end-page: 589
  ident: CR49
  article-title: Cryoballoon vs. radiofrequency ablation for atrial fibrillation: a study of outcome and safety based on the ESC-EHRA atrial fibrillation ablation long-term registry and the Swedish catheter ablation registry
  publication-title: Europace
  doi: 10.1093/europace/euy239
– volume: 3
  start-page: 601
  issue: 7
  year: 2018
  end-page: 608
  ident: CR13
  article-title: Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM study
  publication-title: JAMA Cardiol
  doi: 10.1001/jamacardio.2018.1176
– volume: 205
  start-page: 145
  year: 2018
  end-page: 148
  ident: CR62
  article-title: Impact of rotor ablation in non-paroxysmal AF patients: findings from the per-protocol population of the OASIS trial at long-term follow-up
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2018.05.021
– volume: 26
  start-page: 1298
  issue: 12
  year: 2015
  end-page: 1306
  ident: CR54
  article-title: Long-term results of radiofrequency hot balloon ablation in patients with paroxysmal atrial fibrillation: safety and rhythm outcomes
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/jce.12820
– volume: 10
  start-page: e004672
  issue: 5
  year: 2017
  ident: CR77
  article-title: Acute and long-term effects of full-power electroporation ablation directly on the porcine esophagus
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.116.004672
– volume: 11
  start-page: e005861
  issue: 5
  year: 2018
  ident: CR55
  article-title: Hot balloon versus cryoballoon ablation for atrial fibrillation: lesion characteristics and middle-term outcomes
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.117.005861
– volume: 14
  start-page: e275
  issue: 10
  year: 2017
  end-page: e444
  ident: CR8
  article-title: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2017.05.012
– volume: 7
  start-page: 46
  issue: 1
  year: 2014
  end-page: 54
  ident: CR40
  article-title: In vivo contact force analysis and correlation with tissue impedance during left atrial mapping and catheter ablation of atrial fibrillation
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.113.000556
– volume: 13
  start-page: 830
  issue: 4
  year: 2016
  end-page: 835
  ident: CR63
  article-title: Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2015.12.028
– volume: 18
  start-page: 201
  issue: 2
  year: 2016
  end-page: 205
  ident: CR58
  article-title: One-year clinical outcome after pulmonary vein isolation in persistent atrial fibrillation using the second-generation 28 mm cryoballoon: a retrospective analysis
  publication-title: Europace
  doi: 10.1093/europace/euv092
– volume: 286
  start-page: 56
  year: 2019
  end-page: 60
  ident: CR66
  article-title: Velocity characteristics of atrial fibrillation sources determined by electrographic flow mapping before and after catheter ablation
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2019.02.006
– volume: 4
  start-page: 977
  issue: 8
  year: 2018
  end-page: 986
  ident: CR76
  article-title: Electroporation and its relevance for cardiac catheter ablation
  publication-title: JACC Clin Electrophysiol
  doi: 10.1016/j.jacep.2018.06.005
– volume: 66
  start-page: 2743
  issue: 24
  year: 2015
  end-page: 2752
  ident: CR18
  article-title: Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2015.09.088
– volume: 112
  start-page: 3038
  issue: 20
  year: 2005
  end-page: 3048
  ident: CR23
  article-title: Electrophysiological findings during ablation of persistent atrial fibrillation with electroanatomic mapping and double Lasso catheter technique
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.561183
– volume: 12
  start-page: 1927
  issue: 9
  year: 2015
  end-page: 1934
  ident: CR33
  article-title: Pulmonary vein isolation using the Rhythmia mapping system: verification of intracardiac signals using the Orion mini-basket catheter
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2015.05.019
– volume: 19
  start-page: 775
  issue: 5
  year: 2017
  end-page: 783
  ident: CR42
  article-title: Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values
  publication-title: Europace
– ident: CR43
– volume: 9
  start-page: e002962
  issue: 3
  year: 2016
  ident: CR70
  article-title: Ablation of persistent atrial fibrillation targeting low-voltage areas with selective activation characteristics
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.115.002962
– volume: 169
  start-page: 35
  issue: 1
  year: 2013
  end-page: 43
  ident: CR60
  article-title: Benefits and risks of additional ablation of complex fractionated atrial electrograms for patients with atrial fibrillation: a systematic review and meta-analysis
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2013.08.083
– volume: 20
  start-page: 1459
  year: 2017
  end-page: 1467
  ident: CR45
  article-title: Is less more? Impact of different ablation protocols on periprocedural complications in second-generation cryoballoon based pulmonary vein isolation
  publication-title: Europace
  doi: 10.1093/europace/eux219
– volume: 17
  start-page: 1229
  issue: 8
  year: 2015
  end-page: 1235
  ident: CR36
  article-title: EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation
  publication-title: Europace
  doi: 10.1093/europace/euv057
– volume: 19
  start-page: 1302
  issue: 8
  year: 2017
  end-page: 1309
  ident: CR68
  article-title: Multicentre evaluation of non-invasive biatrial mapping for persistent atrial fibrillation ablation: the AFACART study
  publication-title: Europace
  doi: 10.1093/europace/euw168
– volume: 19
  start-page: 874
  issue: 5
  year: 2017
  end-page: 880
  ident: CR78
  article-title: Five seconds of 50-60 W radio frequency atrial ablations were transmural and safe: an in vitro mechanistic assessment and force-controlled in vivo validation
  publication-title: Europace
– volume: 6
  start-page: 467
  issue: 3
  year: 2013
  end-page: 472
  ident: CR52
  article-title: Pulmonary vein isolation using a visually guided laser balloon catheter: the first 200-patient multicenter clinical experience
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.113.000431
– volume: 4
  start-page: 467
  issue: 4
  year: 2018
  end-page: 479
  ident: CR79
  article-title: High-power and short-duration ablation for pulmonary vein isolation: biophysical characterization
  publication-title: JACC Clin Electrophysiol
  doi: 10.1016/j.jacep.2017.11.018
– volume: 9
  start-page: 1789
  issue: 11
  year: 2012
  end-page: 1795
  ident: CR39
  article-title: The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2012.07.016
– volume: 139
  start-page: 712
  issue: 5
  year: 2019
  end-page: 715
  ident: CR73
  article-title: Left atrial appendage isolation in patients not responding to pulmonary vein isolation
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.118.037451
– volume: 7
  start-page: 117
  issue: 1
  year: 2015
  end-page: 123
  ident: CR34
  article-title: Utility of noninvasive arrhythmia mapping in patients with adult congenital heart disease
  publication-title: Card Electrophysiol Clin
  doi: 10.1016/j.ccep.2014.11.007
– volume: 24
  start-page: 7
  issue: 1
  year: 2013
  end-page: 13
  ident: CR51
  article-title: Acute and long-term clinical outcome after endoscopic pulmonary vein isolation: results from the first prospective, multicenter study
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/j.1540-8167.2012.02427.x
– volume: 60
  start-page: 628
  issue: 7
  year: 2012
  end-page: 636
  ident: CR61
  article-title: Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (conventional ablation for atrial fibrillation with or without focal impulse and rotor modulation) trial
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2012.05.022
– volume: 68
  start-page: 1929
  issue: 18
  year: 2016
  end-page: 1940
  ident: CR71
  article-title: Left atrial appendage isolation in patients with longstanding persistent af undergoing catheter ablation: BELIEF trial
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2016.07.770
– ident: CR82
– volume: 51
  start-page: 843
  issue: 8
  year: 2008
  end-page: 849
  ident: CR59
  article-title: Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2007.10.044
– ident: CR56
– volume: 107
  start-page: 405
  issue: 5
  year: 2018
  end-page: 412
  ident: CR7
  article-title: Five-year clinical outcomes of visually guided laser balloon pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-017-1199-6
– volume: 107
  start-page: 1021
  issue: 11
  year: 2018
  end-page: 1032
  ident: CR65
  article-title: Identification of active atrial fibrillation sources and their discrimination from passive rotors using electrographical flow mapping
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-018-1274-7
– volume: 11
  start-page: e005250
  issue: 2
  year: 2018
  ident: CR10
  article-title: Ten-year clinical outcome after circumferential pulmonary vein isolation utilizing the Hamburg approach in patients with symptomatic drug-refractory paroxysmal atrial fibrillation
  publication-title: Circ Arrhythm Electrophysiol.
  doi: 10.1161/CIRCEP.117.005250
– volume: 3
  start-page: 875
  issue: 8
  year: 2017
  end-page: 883
  ident: CR27
  article-title: Manual versus robotic catheter ablation for the treatment of atrial fibrillation: the man and machine trial
  publication-title: JACC Clin Electrophysiol
  doi: 10.1016/j.jacep.2017.01.024
– volume: 28
  start-page: 289
  issue: 3
  year: 2017
  end-page: 297
  ident: CR35
  article-title: Direct comparison of point-by-point and rapid ultra-high-resolution electroanatomical mapping in patients scheduled for ablation of atrial fibrillation
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/jce.13160
– volume: 31
  start-page: 1344
  issue: 11
  year: 2010
  end-page: 1356
  ident: CR19
  article-title: Substrate and trigger ablation for reduction of atrial fibrillation (STAR AF): a randomized, multicentre, international trial
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehq041
– volume: 36
  start-page: 233
  issue: 3
  year: 2013
  end-page: 242
  ident: CR31
  article-title: Rapid acquisition of high-resolution electroanatomical maps using a novel multielectrode mapping system
  publication-title: J Interven Cardiac Electrophysiol
  doi: 10.1007/s10840-012-9733-y
– volume: 11
  start-page: 973
  issue: 8
  year: 2009
  end-page: 974
  ident: CR24
  article-title: Does image integration improve atrial fibrillation ablation outcomes, or are other aspects of the ablation the key to success?
  publication-title: Europace
  doi: 10.1093/europace/eup192
– volume: 11
  start-page: e006576
  issue: 9
  year: 2018
  ident: CR44
  article-title: Use of ablation index-guided ablation results in high rates of durable pulmonary vein isolation and freedom from arrhythmia in persistent atrial fibrillation patients
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.118.006576
– ident: CR48
– volume: 3
  start-page: 36
  issue: 1
  year: 2017
  end-page: 39
  ident: CR47
  article-title: Pulmonary vein stenosis after second-generation cryoballoon ablation for atrial fibrillation
  publication-title: Heart Rhythm Case Rep
– volume: 7
  start-page: e010777
  issue: 24
  year: 2018
  ident: CR14
  article-title: The FIRE AND ICE trial: what we know, what we can still learn, and what we need to address in the future
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.118.010777
– volume: 19
  start-page: 758
  issue: 5
  year: 2017
  end-page: 768
  ident: CR72
  article-title: Left atrial appendage isolation in addition to pulmonary vein isolation in persistent atrial fibrillation: one-year clinical outcome after cryoballoon-based ablation
  publication-title: Europace
  doi: 10.1093/europace/eux005
– volume: 155
  start-page: 469
  issue: 5
  year: 1995
  end-page: 473
  ident: CR1
  article-title: Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
  publication-title: Arch intern Med.
  doi: 10.1001/archinte.1995.00430050045005
– volume: 105
  start-page: 106
  issue: 2
  year: 2016
  end-page: 116
  ident: CR26
  article-title: Experience matters: long-term results of pulmonary vein isolation using a robotic navigation system for the treatment of paroxysmal atrial fibrillation
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-015-0892-6
– volume: 3
  start-page: 32
  issue: 1
  year: 2010
  end-page: 38
  ident: CR22
  article-title: Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.109.859116
– volume: 321
  start-page: 1059
  issue: 11
  year: 2019
  end-page: 1068
  ident: CR5
  article-title: Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial
  publication-title: JAMA
  doi: 10.1001/jama.2019.0335
– volume: 49
  start-page: 219
  issue: 3
  year: 2017
  end-page: 226
  ident: CR28
  article-title: Significant reduction in procedure duration in remote magnetic-guided catheter ablation of atrial fibrillation using the third-generation magnetic navigation system
  publication-title: J Interv Cardiac Electrophysiol
  doi: 10.1007/s10840-017-0261-7
– volume: 105
  start-page: 992
  year: 2016
  end-page: 1002
  ident: CR32
  article-title: First clinical experience using a novel high-resolution electroanatomical mapping system for left atrial ablation procedures
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-016-1008-7
– volume: 44
  start-page: 473
  issue: 4
  year: 2011
  end-page: 476
  ident: CR46
  article-title: Asymptomatic pulmonary vein stenosis after cryoballoon catheter ablation of paroxysmal atrial fibrillation
  publication-title: J Electrocardiol
  doi: 10.1016/j.jelectrocard.2010.09.007
– volume: 9
  start-page: e003461
  issue: 5
  year: 2016
  ident: CR74
  article-title: Unexpectedly high incidence of stroke and left atrial appendage thrombus formation after electrical isolation of the left atrial appendage for the treatment of atrial tachyarrhythmias
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.115.003461
– volume: 10
  start-page: e005767
  issue: 12
  year: 2017
  ident: CR53
  article-title: Laser balloon or wide-area circumferential irrigated radiofrequency ablation for persistent atrial fibrillation: a multicenter prospective randomized study
  publication-title: Circ Arrhythm Ectrophysiol
  doi: 10.1161/CIRCEP.117.005767
– volume: 5
  start-page: 778
  issue: 7
  year: 2019
  end-page: 786
  ident: CR81
  article-title: Pulmonary vein isolation with very high power, short duration, temperature-controlled lesions: the QDOT-FAST trial
  publication-title: JACC Clin Electrophysiol
  doi: 10.1016/j.jacep.2019.04.009
– volume: 107
  start-page: 405
  issue: 5
  year: 2018
  ident: 158_CR7
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-017-1199-6
– volume: 6
  start-page: 327
  issue: 2
  year: 2013
  ident: 158_CR37
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.113.000374
– volume: 7
  start-page: 117
  issue: 1
  year: 2015
  ident: 158_CR34
  publication-title: Card Electrophysiol Clin
  doi: 10.1016/j.ccep.2014.11.007
– volume: 10
  start-page: e005767
  issue: 12
  year: 2017
  ident: 158_CR53
  publication-title: Circ Arrhythm Ectrophysiol
  doi: 10.1161/CIRCEP.117.005767
– volume: 5
  start-page: 778
  issue: 7
  year: 2019
  ident: 158_CR81
  publication-title: JACC Clin Electrophysiol
  doi: 10.1016/j.jacep.2019.04.009
– volume: 66
  start-page: 2743
  issue: 24
  year: 2015
  ident: 158_CR18
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2015.09.088
– volume: 4
  start-page: 467
  issue: 4
  year: 2018
  ident: 158_CR79
  publication-title: JACC Clin Electrophysiol
  doi: 10.1016/j.jacep.2017.11.018
– volume: 3
  start-page: 601
  issue: 7
  year: 2018
  ident: 158_CR13
  publication-title: JAMA Cardiol
  doi: 10.1001/jamacardio.2018.1176
– volume: 9
  start-page: e003461
  issue: 5
  year: 2016
  ident: 158_CR74
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.115.003461
– volume: 372
  start-page: 1812
  issue: 19
  year: 2015
  ident: 158_CR17
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1408288
– ident: 158_CR48
  doi: 10.1016/j.jacep.2018.07.007
– volume: 11
  start-page: e006576
  issue: 9
  year: 2018
  ident: 158_CR44
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.118.006576
– volume: 20
  start-page: 1459
  year: 2017
  ident: 158_CR45
  publication-title: Europace
  doi: 10.1093/europace/eux219
– volume: 98
  start-page: 480
  issue: 6
  year: 2012
  ident: 158_CR21
  publication-title: Heart
  doi: 10.1136/heartjnl-2011-301107
– volume: 11
  start-page: e005861
  issue: 5
  year: 2018
  ident: 158_CR55
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.117.005861
– volume: 19
  start-page: 758
  issue: 5
  year: 2017
  ident: 158_CR72
  publication-title: Europace
  doi: 10.1093/europace/eux005
– volume: 10
  start-page: e005114
  issue: 7
  year: 2017
  ident: 158_CR16
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.117.005114
– volume: 3
  start-page: 32
  issue: 1
  year: 2010
  ident: 158_CR22
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.109.859116
– volume: 12
  start-page: 1927
  issue: 9
  year: 2015
  ident: 158_CR33
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2015.05.019
– volume: 107
  start-page: 1021
  issue: 11
  year: 2018
  ident: 158_CR65
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-018-1274-7
– volume: 3
  start-page: e000877
  issue: 5
  year: 2014
  ident: 158_CR20
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.114.000877
– volume: 3
  start-page: 36
  issue: 1
  year: 2017
  ident: 158_CR47
  publication-title: Heart Rhythm Case Rep
– volume: 19
  start-page: 775
  issue: 5
  year: 2017
  ident: 158_CR42
  publication-title: Europace
– volume: 11
  start-page: e005250
  issue: 2
  year: 2018
  ident: 158_CR10
  publication-title: Circ Arrhythm Electrophysiol.
  doi: 10.1161/CIRCEP.117.005250
– volume: 18
  start-page: 201
  issue: 2
  year: 2016
  ident: 158_CR58
  publication-title: Europace
  doi: 10.1093/europace/euv092
– volume: 12
  start-page: 1524
  issue: 7
  year: 2015
  ident: 158_CR75
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2015.03.011
– volume: 3
  start-page: 875
  issue: 8
  year: 2017
  ident: 158_CR27
  publication-title: JACC Clin Electrophysiol
  doi: 10.1016/j.jacep.2017.01.024
– volume: 24
  start-page: 7
  issue: 1
  year: 2013
  ident: 158_CR51
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/j.1540-8167.2012.02427.x
– volume: 10
  start-page: e004672
  issue: 5
  year: 2017
  ident: 158_CR77
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.116.004672
– volume: 379
  start-page: 492
  issue: 5
  year: 2018
  ident: 158_CR4
  publication-title: N Engl J Med
– volume: 17
  start-page: 1229
  issue: 8
  year: 2015
  ident: 158_CR36
  publication-title: Europace
  doi: 10.1093/europace/euv057
– volume: 24
  start-page: 711
  issue: 6
  year: 2013
  ident: 158_CR67
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/jce.12075
– volume: 28
  start-page: 289
  issue: 3
  year: 2017
  ident: 158_CR35
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/jce.13160
– volume: 7
  start-page: 46
  issue: 1
  year: 2014
  ident: 158_CR40
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.113.000556
– volume: 14
  start-page: e275
  issue: 10
  year: 2017
  ident: 158_CR8
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2017.05.012
– volume: 286
  start-page: 56
  year: 2019
  ident: 158_CR66
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2019.02.006
– ident: 158_CR43
  doi: 10.1007/s00392-019-01428-8
– volume: 311
  start-page: 498
  issue: 5
  year: 2014
  ident: 158_CR69
  publication-title: JAMA
  doi: 10.1001/jama.2014.3
– volume: 11
  start-page: 663
  issue: 6
  year: 2015
  ident: 158_CR50
  publication-title: Fut Cardiol
  doi: 10.2217/fca.15.68
– volume: 49
  start-page: 219
  issue: 3
  year: 2017
  ident: 158_CR28
  publication-title: J Interv Cardiac Electrophysiol
  doi: 10.1007/s10840-017-0261-7
– volume: 168
  start-page: 581
  issue: 6
  year: 2008
  ident: 158_CR9
  publication-title: Arch Int Med
  doi: 10.1001/archinte.168.6.581
– volume: 112
  start-page: 3038
  issue: 20
  year: 2005
  ident: 158_CR23
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.561183
– volume: 52
  start-page: 1
  issue: 1
  year: 2018
  ident: 158_CR80
  publication-title: J Interv Card Electrophysiol
  doi: 10.1007/s10840-018-0322-6
– volume: 321
  start-page: 1059
  issue: 11
  year: 2019
  ident: 158_CR5
  publication-title: JAMA
  doi: 10.1001/jama.2019.0335
– volume: 339
  start-page: 659
  issue: 10
  year: 1998
  ident: 158_CR15
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199809033391003
– volume: 374
  start-page: 2235
  issue: 23
  year: 2016
  ident: 158_CR6
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1602014
– volume: 29
  start-page: 3029
  issue: 24
  year: 2008
  ident: 158_CR25
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehn453
– volume: 21
  start-page: 581
  issue: 4
  year: 2019
  ident: 158_CR49
  publication-title: Europace
  doi: 10.1093/europace/euy239
– volume: 9
  start-page: 1789
  issue: 11
  year: 2012
  ident: 158_CR39
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2012.07.016
– volume: 205
  start-page: 145
  year: 2018
  ident: 158_CR62
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2018.05.021
– volume: 139
  start-page: 712
  issue: 5
  year: 2019
  ident: 158_CR73
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.118.037451
– volume: 321
  start-page: 1261
  year: 2019
  ident: 158_CR3
  publication-title: JAMA
  doi: 10.1001/jama.2019.0693
– volume: 105
  start-page: 992
  year: 2016
  ident: 158_CR32
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-016-1008-7
– volume: 18
  start-page: 387
  issue: 4
  year: 2007
  ident: 158_CR38
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/j.1540-8167.2007.00760.x
– volume: 19
  start-page: 1302
  issue: 8
  year: 2017
  ident: 158_CR68
  publication-title: Europace
  doi: 10.1093/europace/euw168
– volume: 9
  start-page: e002962
  issue: 3
  year: 2016
  ident: 158_CR70
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.115.002962
– volume: 4
  start-page: 977
  issue: 8
  year: 2018
  ident: 158_CR76
  publication-title: JACC Clin Electrophysiol
  doi: 10.1016/j.jacep.2018.06.005
– volume: 155
  start-page: 469
  issue: 5
  year: 1995
  ident: 158_CR1
  publication-title: Arch intern Med.
  doi: 10.1001/archinte.1995.00430050045005
– volume: 122
  start-page: 2368
  issue: 23
  year: 2010
  ident: 158_CR11
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.110.946806
– volume: 7
  start-page: e010777
  issue: 24
  year: 2018
  ident: 158_CR14
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.118.010777
– volume: 19
  start-page: 874
  issue: 5
  year: 2017
  ident: 158_CR78
  publication-title: Europace
– volume: 42
  start-page: 21
  issue: 1
  year: 2015
  ident: 158_CR41
  publication-title: J Interv Card Electrophysiol
  doi: 10.1007/s10840-014-9947-2
– volume: 28
  start-page: 1247
  issue: 11
  year: 2017
  ident: 158_CR57
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/jce.13310
– volume: 13
  start-page: 830
  issue: 4
  year: 2016
  ident: 158_CR63
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2015.12.028
– volume: 14
  start-page: 192
  issue: 2
  year: 2017
  ident: 158_CR64
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2016.11.008
– ident: 158_CR56
  doi: 10.1111/jce.13989
– volume: 26
  start-page: 1298
  issue: 12
  year: 2015
  ident: 158_CR54
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/jce.12820
– volume: 18
  start-page: 1609
  issue: 11
  year: 2016
  ident: 158_CR2
  publication-title: Europace
  doi: 10.1093/europace/euw295
– volume: 105
  start-page: 106
  issue: 2
  year: 2016
  ident: 158_CR26
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-015-0892-6
– volume: 20
  start-page: 833
  issue: 7
  year: 2009
  ident: 158_CR29
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/j.1540-8167.2009.01454.x
– volume: 36
  start-page: 233
  issue: 3
  year: 2013
  ident: 158_CR31
  publication-title: J Interven Cardiac Electrophysiol
  doi: 10.1007/s10840-012-9733-y
– volume: 51
  start-page: 843
  issue: 8
  year: 2008
  ident: 158_CR59
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2007.10.044
– volume: 29
  start-page: 881
  issue: 6
  year: 2018
  ident: 158_CR30
  publication-title: J Cardiovasc Eelectrophysiol
  doi: 10.1111/jce.13472
– ident: 158_CR82
  doi: 10.1016/j.jacep.2019.06.020
– volume: 31
  start-page: 1344
  issue: 11
  year: 2010
  ident: 158_CR19
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehq041
– volume: 44
  start-page: 473
  issue: 4
  year: 2011
  ident: 158_CR46
  publication-title: J Electrocardiol
  doi: 10.1016/j.jelectrocard.2010.09.007
– volume: 12
  start-page: e007233
  year: 2019
  ident: 158_CR83
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.119.007233
– volume: 68
  start-page: 1929
  issue: 18
  year: 2016
  ident: 158_CR71
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2016.07.770
– volume: 6
  start-page: 467
  issue: 3
  year: 2013
  ident: 158_CR52
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.113.000431
– volume: 60
  start-page: 628
  issue: 7
  year: 2012
  ident: 158_CR61
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2012.05.022
– volume: 11
  start-page: 973
  issue: 8
  year: 2009
  ident: 158_CR24
  publication-title: Europace
  doi: 10.1093/europace/eup192
– volume: 29
  start-page: 257
  issue: 2
  year: 2018
  ident: 158_CR12
  publication-title: J Cardiovasc Elektrophysiol
  doi: 10.1111/jce.13401
– volume: 169
  start-page: 35
  issue: 1
  year: 2013
  ident: 158_CR60
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2013.08.083
SSID ssib044732560
ssj0001285943
Score 2.3884873
SecondaryResourceType review_article
Snippet Purpose of Review Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with high rates of morbidity and mortality. Maintenance of...
Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with high rates of morbidity and mortality. Maintenance of stable sinus rhythm...
Purpose of Review Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with high rates of morbidity and mortality. Maintenance of...
Abstract Purpose of Review Atrial fibrillation (AF), the most common sustained arrhythmia, is associated with high rates of morbidity and mortality....
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 45
SubjectTerms Ablation techniques
AF sources
Anti-arrhythmia drugs
Atrial fibrillation
Cardiology
Catheter ablation
Cryoballoon
Dielectric mapping
Dosage and administration
Drug therapy
Internal Medicine
Medicine
Medicine & Public Health
Patient outcomes
Review
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB5KDqWXkD6SuE2LCoUcEpO1JFtSb9vSJRRaSkggNyHLEgkEb-hu_n9nJO9mnUBy6cEXS35oNJr5JM18AviCxjBGdHWlroIopeG-NAhbS29a13IvTPQpyvd3c3ohf17WlxtHfVFMWKYHzoI7kdL7zlTJ90tBfOE4JYgiVl60LsrEXoo-b2MyhZokpRJ8BfzzaouucwgdjlBRIqauhgyalEcnifkMZ9V4oXtE1Rl5qUTm_9hkb_ish_GUDzZVk6-a7cD2ADLZNDfuNbwI_Rt4-WvYRn8LZynvDyXKpm2OhWPzyKbpBA82oySAm3z7K0tglErxAXohc33HZomIhP25T9RcvIOL2Y_z76flcLhC6WtllqXzwYVaqY626oLuELjhTFkqVbuqC8EE0Wg3UV7zSLmp0qCrm_DW87Z2deO42IWtft6HfWAuEGryRJYWZNRCx0nbdNogeFfOuVBAtRKm9QPzOB2AcWPXnMmpA-yELuoAyws4Wj9zm3k3nqz9jfpoXZM4s9MN1CQ7aJJ9TpMKOKQetjSy8fe8GxIUsJHEkWWnDYIjsof4uYNRTRyRflT8eaUjlooojK0P87uF5UIIxKuNVgXsZZ1Z_zMaV4NwzBSgRto0atS4pL--SoTgKoU2iQKOV3pnB0u0eEJo7_-H0D7AK04rEGld6gC2ln_vwkeEacv2UxqR_wC8Yi61
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEB_OE8QX8dvqKREEH7SyTdImEURWcTmEExEX7i2kaXIKS1d390D_e2fSj7PnceBDX5q0TZOZzG-SmV8AnuFkGCOaulwXQeTScJ8bhK25N7WruRcm-hTl-6k6XMqPx-XxHgzHHfUduL3QtaPzpJab1atfP3-_RYV_M6bBSSIuQ6cYL7RuOPJX4CpaJkWKenQG96VUgg_uQLcGo8susA71VuSItIs-r-bi105sV6L4_3ci_8uSnY-yPLfVmizY4ibc6KEnm3eycgv2Qnsbrh31m-t34EvKBsR-ZvO6i5Bj68jm6VwPtqDUgFV3-zVLEJVK8QF6IXNtwxaJnoR9Pkvf3N6F5eLD1_eHeX_kQu5LZXa588GFUqmGNvCCbhDOof8slSpd0YRggqi0mymveaSMVWnQAM547XldurJyXNyD_XbdhgfAXCAs5YlCLciohY6zumq0QUivnHMhg2LoTOt7PnI6FmNlRyblNAB2RhcNgOUZvBif-dGxcVxa-x2N0ViTmLTTjfXmxPaKaaX0vjFFwpZSEB89upxRxMKL2kVZZvCcRtiSBGLzvOvTFvAniTnLziuETDRL4ucOJjVRT_2k-OkgI5aKKLitDevTreVCCESxlVYZ3O9kZmwzTrkGQZrJQE2kafJT05L2-7dEE65SwJPI4OUgd3ZQr0s67eH_VX8E1zmtQKR1qQPY321Ow2OEabv6SdK9Py2nLqg
  priority: 102
  providerName: Scholars Portal
Title Catheter Ablation of Atrial Fibrillation: State of the Art and Future Perspectives
URI https://link.springer.com/article/10.1007/s40119-019-00158-2
https://www.ncbi.nlm.nih.gov/pubmed/31898209
https://www.proquest.com/docview/2333610687
https://pubmed.ncbi.nlm.nih.gov/PMC7237603
https://doaj.org/article/44ccd9100123432989140f3f1c3baf45
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Ni9UwEB90BfEifltdlwiCBy285qNJvD0f-1iEFREX9hbSNNGFpU_2vb36tzuTfqxdZcFDc2jSNk0mM78kM78AvEFlmBKautJUUZTS8lBahK1lsI1veBA2hezl-7k-OpGfTtXpEBS2Hb3dxy3JrKmnYDdJ9GQ49cULbRj27224o3DuTnK9uuIcl1ILPoL-fqXFqN59DkenKBFPV0P0zL9fO7NQmcj_b3X9h7267kt5bUM126n1A7g_AEy27CXiIdyK3SO4ezxsoT-GrznmD1uTLZveD45tElvm0zvYmgIAzvvbH1gGopSLD9ALme9ats4kJOzLVZDm9gmcrA-_rY7K4WCFMihtd6UP0UeldUvbdNG0CNpwliy1Vr5qY7RR1MYvdDA8UVyqtGjmFrwJvFFe1Z6Lp7DXbbr4HJiPhJgCEaVFmYwwadHUrbEI3LX3PhZQjY3pwsA6TodfnLuJLzl3gFvQRR3geAHvpmd-9pwbN5b-SH00lSS-7Hxjc_HdDcPPSRlCa6uMIKUg1nmcWCaRqiAan6Qq4C31sKNRjdULfghOwJ8kfiy3rBEYkS7Ez-3PSuJoDLPs16OMOMoiF7Yubi63jgshEKvWRhfwrJeZqc6oWC1CMVuAnknT7KfmOd3Zj0wGrrNbkyjg_Sh3btBC2xsa7cX_FX8J9zitM-TVp33Y211cxlcIxnbNQR57lNarg7yggemxNJT-OvwNSSIn3Q
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwEB1BkaCXiu-GFjASEgeI2NhOHPe2rFgt0FYItVJvluPYAqnKInb7_5lxnKVZUCUOucRO4nhmPM_2zDPAaxwMQ0BXl9eFF7nU3OUaYWvudGMb7oQOLkb5nlaLc_n5orxINDmUC7O1f_9-JYmUDCe8eKHnQqnehjsSZ8oUvjerZoPuSKkEH6B-v75Sl33QHNqkyBFFFyln5t-vHfmlSN__9yB9zUttR1BubaNG7zS_D3sJVrJprwcP4JbvHsLdk7Rx_gi-xUw_7EM2bfroN7YMbBrP7GBzCvu_7G8fsQg_qRQfoBcy27VsHqlH2Nc_qZmrx3A-_3g2W-TpOIXclUqvc-u89aVSLW3O-bpFqIZzY6lUaYvWe-1FVduJcjUPlI0qNTq3CW8cb0pbVpaLJ7DTLTu_D8x6wkmO6NG8DLWow6Sp2lojXFfWWp9BMXSmcYlrnI68uDQbluQoADOhiwRgeAZvN8_87Jk2bqz9gWS0qUks2fEGKo9JRmekdK7VRcSNUhDXPE4ngwiFE40NsszgDUnYkC1j85xNKQn4k8SKZaYVwiEaAfFzh6OaaINuVPxq0BFDRRS41vnl1cpwIQQi1KpWGTztdWbTZhxONQIwnYEaadPop8Yl3Y_vkQJcxWAmkcG7Qe9MGntWN3Tas_-r_hLuLc5Ojs3xp9MvB7DLaaUhrj8dws7615V_jnBs3byIdvgbRzQjEQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BkSouFeWZUsBISBwg6sZ24pjbdiEqr6pCVOrNchybVqqyVXf7_5lxHjQFVeKQS-wkjmfG89me-QzwBgfDENDVpWXmRSo1d6lG2Jo6XduaO6GDi1G-h8XBsfxykp9cy-KP0e7DlmSX00AsTe1676IJe2PimySqMpwG44X-DGV9F-7hTCVu1C6KxaBRUirBhwlAt-pS5l0oHVqqSBFbZ30mzb9fO_FWkdT_76H7mu-6GVd5Y3M1-qzqAWz1YJPNO-3Yhju-fQib3_vt9EfwI-b_Yc-yed3FxLFlYPN4kgerKBngvLv9gUVQSqX4AL2Q2bZhVSQkYUd_EjZXj-G4-vRzcZD2hyykLld6nVrnrc-VamjLzpcNAjicMUulcps13msvitLOlCt5oBxVqdHlzXjteJ3bvLBcPIGNdtn6Z8CsJ_TkiDTNy1CKMszqoik1gnhlrfUJZENnGtczkNNBGOdm5E6OAjAzukgAhifwbnzmouPfuLX2PslorEnc2fHG8vKX6U3RSOlco7OIJqUgBnqcZAYRMidqG2SewFuSsCELx-Y52ycq4E8SV5aZFwiSaFzEz-1OaqJluknx60FHDBVROFvrl1crw4UQiFuLUiXwtNOZsc04yGqEZToBNdGmyU9NS9qz00gMrmKIk0jg_aB3ph-RVrd02s7_VX8Fm0cfK_Pt8-HX53Cf0_JDXJTahY315ZV_gRhtXb-MZvgb7WUrWA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Catheter+Ablation+of+Atrial+Fibrillation%3A+State+of+the+Art+and+Future+Perspectives&rft.jtitle=Cardiology+and+therapy&rft.au=Rottner%2C+Laura&rft.au=Bellmann%2C+Barbara&rft.au=Lin%2C+Tina&rft.au=Reissmann%2C+Bruno&rft.date=2020-06-01&rft.pub=Springer+Healthcare&rft.issn=2193-8261&rft.eissn=2193-6544&rft.volume=9&rft.issue=1&rft.spage=45&rft.epage=58&rft_id=info:doi/10.1007%2Fs40119-019-00158-2&rft.externalDocID=10_1007_s40119_019_00158_2
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2193-8261&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2193-8261&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2193-8261&client=summon